Friday, 22 Mar 2019

You are here

HERO Trial - Hydroxychloroquine Fails in Hand Osteoarthritis

UK researchers have treated 248 patients with moderate to severe hand pain and radiographic osteoarthritis (OA) and demonstrated no benefit after 12 months of hydroxychloroquine (HCQ), according to a recent article in Annals of Internal Medicine.

A randomized, double-blind, placebo-controlled clinical trial from 13 centers in England enrolled adults with hand OA and pain ≥4 (0-10 VAS) with evidence of radiographic hand osteoarthritis. The supposition was that control of inflammation and low grade synovitis would forestall the progression of OA. 

At 6 months (the primary endpoint), the mean hand pain was similar between groups (5.49 PBO vs 5.66 HCQ). No other significant treatment differences were found at 3, 6, or 12 months for any secondary outcomes.

Whlle X-rays and grayscale ultrasonography were done at baseline, these were not assessed at the endpoints. 

HCQ is one of many agents to have been tested, and failed at altering the course or symptom severity of hand OA.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Risky Painkillers Commonly Prescribed for Osteoarthritis

Published guidelines warn that treating osteoarthritis (OA) with opioids and benzodiazepines can boost patients' risk of falling. Nevertheless, physicians in a large health system were prescribing those drugs for the condition nearly a third of the time, often in the vulnerable elderly, according to a study reported here.

Tramadol May be Associated with Increased Mortality in Osteoarthritis

JAMA reports that tramadol use in adults with osteoarthritis (OA) may be associated with increased all-cause mortality (compared with nonsteroidal anti-inflammatory drugs).

TKR - One or Two at a Time?

His would-be surgeon tried mightily to talk him out of a bilateral knee replacement. At 340 pounds, the patient's BMI -- above 43 -- was a significant contraindication. 

But the patient -- Nick Yphantides, MD, chief medical officer for California's San Diego County -- told MedPage Today he "aggressively" insisted, threatening to find another surgeon if he had to.

Older Men Less Likely to be Assessed and Treated for Osteoporosis

A study from the University of Washington in Seattle find that men with osteoporosis were less likely to be assessed by dual-energy X-ray absorptiometry (DXA); vitamin D measurements and were less like to receive calcium/vitamin D and bisphosphonate prescriptions. 

Hip Replacements Lasting 25 Years

Lancet reports that, based on a literature review and metanalysis, patients and surgeons can expect a hip replacement to last 25 years in around 58% of patients.

In the USA, there is an estimated 400,000 total hip arthroplasties (THA) annually. UK invesigators set out to answer the question: how long does a hip replacement last?